Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
Saved in:
| Title: | Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. |
|---|---|
| Authors: | Angelopoulou MK; Department of Hematology, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Vassilakopoulos TP; Department of Hematology, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Batsis I; Hematology and Bone Marrow Transplantation Department, General Hospital of Thessaloniki Papanikolaou, Thessaloniki, Greece., Sakellari I; Hematology and Bone Marrow Transplantation Department, General Hospital of Thessaloniki Papanikolaou, Thessaloniki, Greece., Gkirkas K; 2nd Department of Internal Medicine, Faculty of Medicine, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Pappa V; 2nd Department of Internal Medicine, Faculty of Medicine, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Giannoulia P; Department of Hematology, Evaggelismos General Hospital, Athens, Greece., Apostolidis I; Department of Hematology, Evaggelismos General Hospital, Athens, Greece., Apostolopoulos C; Third Department of Medicine, 'Sotiria' General Hospital of Thoracic Diseases, Hematology Unit, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Roussou P; Third Department of Medicine, 'Sotiria' General Hospital of Thoracic Diseases, Hematology Unit, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Panayiotidis P; 1st Department of Propedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Dimou M; 1st Department of Propedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Kyrtsonis MC; 1st Department of Propedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Palassopoulou M; Department of Hematology, Larissa University Hospital, University of Thessalia, Larissa, Greece., Vassilopoulos G; Department of Hematology, Larissa University Hospital, University of Thessalia, Larissa, Greece., Moschogiannis M; Department of Hematology, Athens Medical Center, Athens, Greece., Kalpadakis C; Department of Hematology, Heraklion University Hospital, University of Crete, Heraklion, Greece., Margaritis D; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Spyridonidis A; Bone Marrow Transplantation Unit, University of Patras, Patras, Greece., Michalis E; Department of Clinical Hematology, 'G.Gennimatas' Athens General Hospital, Athens, Greece., Anargyrou K; Department of Hematology, Air Force Hospital, Athens, Greece., Repousis P; Department of Hematology, Metaxa Hospital, Pireaus, Greece., Hatzimichael E; Department of Hematology, Ioannina University Hospital, University of Ioannina, Ioannina, Greece., Bousiou Z; Hematology and Bone Marrow Transplantation Department, General Hospital of Thessaloniki Papanikolaou, Thessaloniki, Greece., Poulakidas E; Department of Hematology, 401 Military Hospital of Athens, Athens, Greece., Grentzelias D; Hygeia General Hospital, Athens, Greece., Harhalakis N; Department of Hematology, Evaggelismos General Hospital, Athens, Greece., Pangalis GA; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Anagnostopoulos A; Hematology and Bone Marrow Transplantation Department, General Hospital of Thessaloniki Papanikolaou, Thessaloniki, Greece., Tsirigotis P; 2nd Department of Internal Medicine, Faculty of Medicine, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece. |
| Source: | Hematological oncology [Hematol Oncol] 2018 Feb; Vol. 36 (1), pp. 174-181. Date of Electronic Publication: 2017 Feb 20. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
